How Elon Musk sold 10 million Tesla shares and increased his Tesla holdings
Tesla CEO Elon Musk sold a massive stake in his company over the past several weeks. And yet he owns 564,000 more shares than he did at the start of the selling
Read MoreTesla CEO Elon Musk sold a massive stake in his company over the past several weeks. And yet he owns 564,000 more shares than he did at the start of the selling
Read MoreFacebook has sold ads promoting anti-vaccine messages, comparing the US government’s response to Covid-19 to Nazi Germany, casting doubt on the result of the 2020 election, and even pushing political
Read MoreTesla says it has officially moved its corporate headquarters from Silicon Valley to a large factory under construction outside of Austin, Texas. The company made the announcement late Wednesday in
Read MoreRobotics engineering student Ken Pillonel wowed the internet last month with a wild hack that managed to put a working USB-C port inside an iPhone X for a fully functional USB-C iPhone.
Read MoreMore and more official papers are being turned into PDF documents, and you may be asked to sign one electronically while you’re away from your computer (here, by the way,
Read MoreApple will continue to accept App Store app submissions through the holidays, marking a shift from the company’s approach in the past. Typically, Apple doesn’t let developers make submissions through
Read MoreNetflix just brought its new gaming service to all subscribers on Android, but now it has officially come to iOS. The service gives users access to a limited selection of mobile
Read MoreNASA is pushing back its target date for returning humans to the Moon, now eyeing a crewed lunar landing in 2025 instead of 2024 as originally planned. NASA blames the
Read MoreEcobee now gives you the option to pair its smart home monitoring devices with a professional security service. With the company’s new service, which replaces the Haven service it formerly offered, you
Read MoreIn our Toxicology Reports (TR) paper on COVID-19 that examined myriad issues associated with the ongoing mass inoculations (hereafter called the TR paper), we also evaluated the ratio of costs to benefits
Read More
Recent Comments